Search for: "Mylan Pharmaceuticals" Results 601 - 620 of 739
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Oct 2009, 8:27 am
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 On October 19, 2009, the Department of Justice announced that four pharmaceutical manufacturers, Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals, and Ortho McNeil Pharmaceutical settled… [read post]
20 Oct 2009, 1:15 am
The US Attorney’s office in New Hampshire announced yesterday the settlement of a qui tam alleging that four pharmaceutical companies - Mylan Pharmaceuticals, UDL Laboratories, Aztra-Zeneca Pharmaceuticals, and Ortho-McNeill - mischaracterized their prescription drugs to state Medicaid programs. [read post]
18 Oct 2009, 5:42 pm
Teva announced that it has filed a lawsuit against Mylan Pharmaceuticals, Inc., Mylan Inc. and Natco Pharma Ltd. for patent infringement in the [...] [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
6 Oct 2009, 12:41 am
Mylan Pharmaceuticals Inc. et al., 1-08-cv-00889(DED October 2, 2009, Memorandum Order) (Robinson, J.) [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
27 Sep 2009, 5:13 pm
Opinion below (Federal Circuit) Petition for certiorari (08-1461) Petition for certiorari (08-1463) Brief in opposition Petitioner's reply (08-1461) Petitioner's reply (08-1463) Brief amicus curiae of Generic Pharmaceutical Association [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs)   Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
2 Sep 2009, 11:22 pm
Mylan Laboratories, Inc., 2008 WL 4813311, at *6-7 (D. [read post]
1 Sep 2009, 4:39 am
In April, 2008, the FDA announced a recall of the drug Digitek® (Digoxin) distributed by Mylan Bertek Pharmaceuticals, Inc. and UDL Laboratories, Inc. [read post]
28 Aug 2009, 8:11 am
Mylan Pharmaceuticals Inc., Matrix Laboratories Ltd. and Matrix Laboratories Inc. [read post]
19 Aug 2009, 6:25 am
The Perry settlement arose from the failed attempt by Mylan Laboratories, Inc. to acquire King Pharmaceuticals, Inc. in 2004. [read post]
12 Aug 2009, 8:09 am
– Reports that WIPO intends to impose ‘Global Patenting Regime’ on developing world (Spicy IP) Members of Human Rights Expert Committee at UN question patents on food (Intellectual Property Watch) The impact of the global financial crisis on biotechnology development (BiotechBlog) Australia: Patent cures, not genes, cancer patients argue: easier said than done – Senate inquiry into gene patenting (IP Osgoode) Canada: RCMP shuts down counterfeit drug ring… [read post]
11 Aug 2009, 7:51 am
Several product liability lawsuits have been filed against generic drug giant Mylan, Inc. and other pharmaceutical companies related to the manufacture of pain patches. [read post]
8 Aug 2009, 1:43 am
A Texas law firm is targeting generic drug giant Mylan Inc., along with other pharmaceutical companies, in product liability lawsuits related to the manufacture of pain patches. [read post]
6 Aug 2009, 11:24 pm
Mylan Labs., Inc., 520 F.3d 1358, 1364 (Fed. [read post]
1 Aug 2009, 8:57 am
Pharmaceutical companies occasionally submit data to the FDA they know is false. [read post]